Additional File 9 of Carbohydrates and Ginsenosides in Shenmai Injection Jointly Improve Hematopoietic Function During Chemotherapy-Induced Myelosuppression in Mice

Shiyu Zhang,Tingting Ye,Li Liu,Xiaohui Fan,Xiaoyan Lu,Jing Qian

DOI: https://doi.org/10.6084/m9.figshare.21507439

2022-01-01

Abstract:Additional file 9: Table S6. GO analysis of common DEGs in S and S+Rg groups.

What problem does this paper attempt to address?

Additional File 5 of Carbohydrates and Ginsenosides in Shenmai Injection Jointly Improve Hematopoietic Function During Chemotherapy-Induced Myelosuppression in Mice

Shiyu Zhang,Yinxiao Mi,Tingting Ye,Xiaoyan Lu,Li Liu,Jing Qian,Xiaohui Fan

DOI: https://doi.org/10.6084/m9.figshare.21507427

2022-01-01

Abstract:Additional file 5: Table S2. DEGs in Model, S+Rg, S, and Rg groups.
Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice

Shiyu Zhang,Yinxiao Mi,Tingting Ye,Xiaoyan Lu,Li Liu,Jing Qian,Xiaohui Fan

DOI: https://doi.org/10.1186/s13020-022-00678-5

2022-11-04

Abstract:Background: Shenmai injection (SMI), a traditional Chinese medicine (TCM) injection prepared from Red ginseng and Ophiopogon japonicus, is widely used in clinics to treat chemotherapy-induced myelosuppression. Similar to other TCM injections, SMI contains a high amount of carbohydrates (fructose, sucrose, and maltose) in addition to the bioactive substances, specifically ginsenosides (Rg1, Re, and Rb1). To date, the role of these carbohydrates in the hematopoietic function of SMI remains unclear. Purpose: We aimed to investigate the hematopoietic effects and potential mechanisms of SMI and its components, focusing on the carbohydrates present in SMI. Experimental design/methods: First, we evaluated the hematopoietic effect of SMI on 5-fluorouracil (5-FU)-induced myelotoxicity in a tumor-bearing mouse model. Then we prepared mixtures of ginsenosides and carbohydrates according to their proportions in SMI and evaluated their hematopoietic function in mice with 5-FU-induced myelosuppression. Finally, hematopoiesis-related molecular networks were built based on RNA sequencing (RNA-seq) of the bone marrow stromal cells (BMSCs), and the potential mechanisms of carbohydrates and ginsenosides were evaluated. Results: SMI attenuated 5-FU-induced myelotoxicity in tumor-bearing mice. Both ginsenosides and carbohydrates increased the bone marrow nucleated cell (BMNC) count and improved the bone marrow morphology in myelosuppressive mice; they promoted the proliferation of BMSCs derived from those myelosuppressive mice. Bioinformatics analyses revealed ECM-receptor interaction, Hippo signaling, and Wnt signaling are common pathways regulated by both ginsenosides and carbohydrates; Gstt1, Gstp2, Gsta4 and Oplah in Glutathione metabolism pathway and Cd19, Cd79a, and Cd79b in B cell receptor pathway are uniquely regulated genes related to carbohydrates but not ginsenosides. Conclusions: Carbohydrates may collaborate with ginsenosides and contribute to the hematopoietic function of SMI. Carbohydrates could be considered as a bioactive component in this TCM injection.
Shenfu Injection Protects Against Myelosuppression from Chemotherapy

Yan Lu,Li-Na Liu,Hong-Gang Lou,Xiang Xu

DOI: https://doi.org/10.5246/jcps.2012.04.047

2012-01-01

Journal of Chinese Pharmaceutical Sciences

Abstract:Cyclophosphamide is used to treat a variety of tumors.However,the success of the treatment is limited due to severe myelosuppression caused by cyclophosphamide.Administration of cyclophosphamide could significantly decrease white blood cells (WBCs),platelets,red blood cells (RBCs),as well as hemoglobin level.The aim of this research is to investigate the protective role of Shenfu injection against cyclophosphamide induced myelosuppression.The results showed that Shenfu injection can markedly enhance the level of WBCs,platelets,RBCs,and hemoglobin of myelosuppressed rat.The level of WBCs,platelets,RBCs,and hemoglobin were increased by 70％-100％,80％-90％,10％-20％ and 10％-20％,respectively.Furthermore,the protective role of Shenfu injection against myelosuppression was confirmed by the microscopic observation of bone marrow sections.In conclusion,Shenfu injection has a potential protective effect against cyclophosphamide-induced myelotoxicity.
Additional File 9 of CircCDKN2B-AS1 Interacts with IMP3 to Stabilize Hexokinase 2 Mrna and Facilitate Cervical Squamous Cell Carcinoma Aerobic Glycolysis Progression

Yanan Zhang,Liang Zhao,Shizhou Yang,Yixuan Cen,Tingjia Zhu,Lingfang Wang,Lili Xia,Yuwan Liu,Jian Zou,Junfen Xu,Yang Li,Xiaodong Cheng,Weiguo Lü,Xinyu Wang,Xian-Jin Xie

DOI: https://doi.org/10.6084/m9.figshare.13466847

2020-01-01

Abstract:Additional file 9: Table S5. All proteins predicted by RBPmap.
Additional File 6 of Uric Acid Induced Hepatocytes Lipid Accumulation Through Regulation of Mir-149-5p/fgf21 Axis

Shenghui Chen,Dan Chen,Hua Yang,Xinyu Wang,Jinghua Wang,Chengfu Xu

DOI: https://doi.org/10.6084/m9.figshare.11870712

2020-01-01

Abstract:Additional file 6: Table S2. Differential expressed miRNAs identified by microarray analysis of liver samples from SCD, HFD and HFD + A fed mice.
[Antiangiogenesis of Ginsenoside Rg3 in Severe Combined Immunodeficient Mice with Human Ovarian Carcinoma].

Zimin Pan,Dafeng Ye,Xing Xie,Huaizeng Chen,Weiguo Lu

DOI: https://doi.org/10.3760/j.issn:0529-567x.2002.04.012

2002-01-01

Abstract:OBJECTIVE:To investigate the antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient (SCID) mice with human ovarian carcinoma by detecting vascular endothelial growth factor (VEGF) mRNA, VEGF protein level and microvascular density (MVD).METHODS:The SCID mice with human ovarian carcinoma SKOV3 cells were treated with Rg3 (300 microgram 400 microl(-1) mouse(-1)), mice with phosphate buffered solution (PBS) and without Rg3 and PBS were used as control. Tumor volume, metastasis, ascites, VEGF mRNA, VEGF protein and MVD were detected. The level of VEGF mRNA in tumor tissue was determined by relative quantative reverse transcription polymerase chain reaction. VEGF protein level in sera and ascitic fluids were determined by enzyme-linked immunosorbent assay. MVD was calculated by immunohistochemistry (anti-CD34).RESULTS:(1) No ascites was formed and the size of metastasis decreased in SKOV3/Rg3 group. (2) Expression of VEGF mRNA level in SKOV3/Rg3 group (119 +/- 16) was lower significantly than those of the control groups (254 +/- 4, 273 +/- 44, respectively, P < 0.05). (3) Serum VEGF level in SKOV3/Rg3 group [(14.6 +/- 0.7) pg/ml] was lower significantly than those of SKOV3 group and SKOV3/PBS group [(18.5 +/- 2.1) and (20.5 +/- 1.7) pg/ml, respectively, P < 0.05]. (4) MVD in tumor tissues of SKOV3/Rg3 group (43 +/- 7) was lower than that of each control group (65 +/- 12, 73 +/- 10, respectively, P < 0.05).CONCLUSION:Ginsenoside Rg3 can block angiogenesis and inhibit tumor growth and metastasis by down regulating the expression of VEGF mRNA and protein and reducing microvascular density.
Study on the Effect of Ginsenosides Rb on Blood of Tumor Mice

Mengmeng Zheng,Wenxiu Zheng,Wei Wang,Hong Guo,Hui Cao,Xiaowei Cui,Shanshan Wang,Chunchao Han

DOI: https://doi.org/10.1155/2019/5476076

2019-08-18

Abstract:Objective: The blood of cancer patients is in a state of hypercoagulability, easily leading to thrombosis. Anemia is also a complication of tumors. Anemia and thrombosis affect the treatment of tumor patients. Methods: Ginsenosides Rb were extracted from the stems and leaves of American ginseng using water-saturated ethanol and ethyl acetate in silica gel column. Tumor mice model was established by injecting H22 hepatocellular carcinoma cells into the axilla of mice. Mice were randomly divided into 6 groups: normal control group, model control group, positive control group, low dose group (7 mg/kg), middle dose group (14 mg/kg), and high dose group (35 mg/kg). After 18 days, the blood was obtained by picking the eyeball of mice. The levels of red blood cells (RBC), hemoglobin (HGB), neutrophils/lymphocytes radio (NLR), platelets (PLT), platelet distribution width (PDW), fibrinogen (FIB), and D-Dimer (D-D) were measured and compared in each group of mice. Results: The content of obtained ginsenosides Rb reached 90.05%. This extraction process was simple and reliable. Middle dose of ginsenosides Rb could significantly increase RBC and HGB levels (P<0.05). Moreover, ginsenosides Rb could significantly reduce NLR, PLT, PDW, FIB, and D-D (P<0.01). Conclusion: ginsenosides Rb could significantly improve anaemia and hypercoagulation of blood in cancer mice. Ginsenosides Rb are a potential anticoagulant and antianemia drug in treating cancer.
Echinacoside Improves Hematopoietic Function in 5-Fu-induced Myelosuppression Mice

Saisai Wang,Gang Zheng,Shousheng Tian,Yan Zhang,Lijuan Shen,Yongchol Pak,Yong Shen,Jing Qian

DOI: https://doi.org/10.1016/j.lfs.2015.01.002

IF: 6.78

2015-01-01

Life Sciences

Abstract:AIMS:We aimed to investigate the effects of echinacoside (ECH) on hematopoietic function in 5-FU-induced bone marrow depression mice.MAIN METHODS:In vitro, after stimulation with ECH, the proliferation ability of bone marrow (BM) cells and bone marrow stromal cells (BMSCs) derived from myelosuppression mice were assessed by CCK8 assay and morphology, respectively. In vivo, 5-FU-induced myelosuppression or control mice were intragastrically administrated with either ECH at 15 mg/kg or the equal volume of normal saline daily for 12 days before BM cells were isolated for colony-forming cell assay. Meanwhile, BMSCs were cultured for 4 weeks before cells were observed for growth pattern, cell culture supernatants were collected for GM-CSF secretion by ELISA, and RNA of the cells were extracted for EPO and GM-CSF RT-PCR. BM cells or BMSCs stimulated with ECH for 24 h or 48 h were collected for protein extraction and Western blotting.KEY FINDINGS:ECH stimulated the growth of BM cells but not BMSCs derived from 5-FU treated mice. The intragastric administration of ECH in 5-FU treated mice could increase the number of total hematopoietic progenitor cells and GM progenitor cells to healthy control mice level, but not BFU progenitor cells. BMSCs from ECH treated myelosuppression mice grew more vigorously and expressed more GM-CSF, but not EPO. ECH activated the PI3K signaling pathway in 5-FU suppressed BM cells.SIGNIFICANCE:ECH could improve the hematopoietic function of bone marrow in 5-FU-induced myelosuppression mice. ECH can be considered as an alternative effective therapy for patients during chemotherapy or HSC transplantation.
Transcriptome Profiling Analysis Reveals the Potential Mechanisms of Three Bioactive Ingredients of Fufang E'jiao Jiang During Chemotherapy-Induced Myelosuppression in Mice

Xue Li,Yan Zhang,Zhuping Hong,Shuqing Gong,Wei Liu,Xiangshan Zhou,Yangen Sun,Jing Qian,Haibin Qu

DOI: https://doi.org/10.3389/fphar.2018.00616

2018-06-13

Abstract:Although multiple bioactive components have been identified in Fufang E'jiao Jiang (FEJ), their hematopoietic effects and molecular mode of action in vivo are still not fully understood. In the current study, we analyzed the effects of martynoside, R-notoginsenoside R2 (R2), and 20S-ginsenoside Rg2 (Rg2) in a 5-fluorouracil-induced myelosuppression mouse model. Bone marrow nucleated cells (BMNCs) counts, hematopoietic progenitor cell colony-forming unit (CFU) assay, as well as flow cytometry analysis of Lin-/c-kit+/Sca-1+ hematopoietic stem cell (HSC) population were conducted, and bone marrow cells were subjected to RNA sequencing. The transcriptome data were processed based on the differentially expressed genes. The results of the analysis show that each of the three compounds stimulates BMNCs and HSC growth, as well as burst-forming unit-erythroid and colony-forming unit granulocyte-monocyte colony expansion. The most relevant transcriptional changes appeared to be involved in regulation of hematopoietic cell lineage, NF-κB and TNF-α signaling, inhibition of inflammation, and acceleration of hematopoietic cell recovery. Notably, the individual compounds shared similar but specified transcriptome profiles. Taken together, the hematopoietic effects for the three tested compounds of FEJ are confirmed in this myelosuppression mouse model. The transcriptome maps of these effects provide valuable information concerning their underlying mechanisms and provide a framework for the continued study of the complex mode of action of FEJ.
Study on Synergic Effect of Shengmai Injection and Adriamycin

WANG Peng,CHEN Zhen,MENG Zhi-qiang,HUANG Wen-xia,LIU Lu-ming

DOI: https://doi.org/10.3969/j.issn.1006-3250.2006.06.019

2006-01-01

Abstract:Objevtive:To find out if Shengmai in jection can enhance the effect of anti-tumor efficacy of ADM and if it can also improve the immunological function and reduce the side-effect of chemotherapy.Methods:S180 sarcoma bearing mice models were established and then randomized into five groups,including control group,ADM group,Shengmai injection(high,middle and low dose) combined with ADM groups.There were 10 mice in each group.The five groups were injected introperitoneally with same amout of natural saline,ADM 2mg/kg and Shengmai injection(14ml/kg,7ml/kg and 3.5ml/kg)plus ADM 2mg/kg respectively,once a day for 14 days.After that,killed them and studied the tumor-weight-inibiting rates and the index of immunological function,liver and renal function and the blood cell in the peripheral blood.Result:(1)The tumor-weight-inhibiting rates were higher in each Shengmai injection plus ADM group than that in the ADM group(P0.05);(2) Compared with the control group,the level of CD3、CD4、CD4/CD8、IgG、IgM and IgA in ADM group were lower(P0.05).But in the three Shengmai injection group combined with ADM they were higher than that in control group and ADM group,which showed significant difference (P0.05).(3)The level of serum ALT and BUN were higher in ADM group with lower level of WBC,Hb and PLT in the peripheral blood.But in the three Shengmai injection plus ADM groups the level of serum ALT and BUN were lower and the level of blood cell were higher than that in the ADM gorup(P0.05).Conclusion:Shengmai injection can enhance the anti-tumor efficacy of ADM chemotherapy and reduce it's side-effects.
Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice

Jinxu Wang,Xin Tong,Peibo Li,Hui Cao,Weiwei Su

DOI: https://doi.org/10.1016/j.jep.2011.12.019

IF: 5.195

2012-02-01

Journal of Ethnopharmacology

Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Radix Codonopsis and Radix Astragali, of which Shenqi Fuzheng Injection (SFI) is composed, are commonly used in traditional Chinese medicine to improve immune function against chronic diseases.AIM OF THE STUDY: The present study was thus designed to systematically elucidate the in vivo immuno-enhancement effects of SFI in immunosuppressed mice induced by cyclophosphamide (Cy) treatment.MATERIALS AND METHODS: Balb/c mice were injected intraperitoneally (i.p.) once daily with low-dose (2.5 g raw materials/kg), intermediate-dose (5 g raw materials/kg), high-dose (10 g raw materials/kg) of SFI for 10 consecutive days, respectively, accompanied by i.p. injection of Cy (80 mg/kg) on Days 4-6.RESULTS: Compared with vehicle group, low-, intermediate- and high-dose SFI treatment accelerated recovery dose-dependently of spleen index, peripheral white blood cell and bone marrow cell counts, enhanced T cell and B cell proliferation responses, as well as splenic nature killer cell activity and peritoneal macrophage phagocytosis, and restored the level of interleukin-2 in the serum. Furthermore, SFI treatment promoted recovery of the amount of peripheral white blood cells on Day 6, rather than recombinant human Granulocyte Colony-Stimulating Factor (rhG-CSF) did.CONCLUSIONS: These results demonstrate, for the first time, that chronic treatment with SFI results in accelerating recovery of immunosuppression in Cy-treated mice, which is competent in taking into consideration for both precautions and remedy. Our findings provide experimental evidences for further researches and clinical application in cancer patients undergoing chemotherapy.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
Pharmacological and transcriptome profiling analyses of Fufang E'jiao Jiang during chemotherapy-induced myelosuppression in mice

Yan Zhang,Tingting Ye,Zhuping Hong,Shuqing Gong,Xiangshan Zhou,Haibin Liu,Jing Qian,Haibin Qu

DOI: https://doi.org/10.1016/j.jep.2019.111869

2019-06-28

Abstract:Ethnopharmacological relevance: Fufang E'jiao Jiang (FEJ), a famous traditional Chinese medicine formula from "Liangyi Ointment", consists of five crude drugs, Colla corii asini, Radix Ginseng Rubra, Radix Rehmanniae Preparata, Codonopsis pilosula, and Crataegus pinnatifida Bge. It has pronounced functions of qi-nourishing and blood-activating. Recently, it has been widely used in China as a medication against myelosuppression in cancer treatment. Aim of the study: We aimed to investigate the complex mode of action and underlying mechanisms of Fufang E'jiao Jiang (FEJ) regarding its hematopoietic effect. Main methods: Mice were divided into 5 groups of control, model, high dose FEJ (HFEJ), medium dose FEJ (MFEJ) and low dose FEJ (LFEJ). After 10 days from the administration, bone marrow cells (BMCs) were extracted for nucleated cells counts, flow cytometry analysis of hematopoietic stem cells (HSCs) population, as well as hematopoietic progenitor cells (HPCs) colony-forming unit (CFU) assay. A portion of bone marrow nucleated cells (BMNCs) of MFEJ group were prepared for RNA sequencing (RNA-Seq). The transcriptome data were analyzed based on the differentially expressed genes (DEGs). The molecular mechanisms of FEJ were deducted based on the biological processes and protein-protein interaction (PPI) network. Results: FEJ could significantly increase the percentage of HSCs and the quantities of BFU-E and CFU-GM in BMSCs. FEJ could stimulate the proliferation of HSC and the differentiation of HPC to all lineages, which may thereby accelerate the recovery of hematopoietic function in myelosuppressive mice. By providing transcriptome profile we highlighted several genes and biological processes that might be applicable for FEJ to treat chemotherapy-induced myelosuppression. GO analysis showed that the co-expressed DEGs in FEJ vs model and model vs control group were involved in biological processes including ossification, osteoblast differentiation, bone mineralization and bone development. The KEGG pathway analysis pointed out ECM-receptor interaction and PI3K-AKT signaling pathway as the most relevant pathways to the function of FEJ on myelosuppression. PPI network showed MMP2 and COL1A1 were the relatively large nodes. Conclusion: FEJ has the hematopoietic effect in chemotherapy-induced myelosuppression mice. It might be achieved by improving the proliferative capacity of HSCs and the differentiation ability of HPCs. The molecular mode of action of FEJ might be the improvement of the bone marrow microenvironment via ECM-receptor interaction, the promoted proliferation of HSC through regulation of PI3K-AKT signaling pathway, and the involvement of osteoblasts and osteoclasts. MMP2 and COL1A1 appear to be the key relevant regulatory molecules. These results provide significant insight into the hematopoietic effects of FEJ in myelosuppression and point out novel targets for future validating analyses.
Supplementary Table S1 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Shujuan Du,Xiaoting Chen,Xiao Han,Yuyan Wang,Dan Yu,Ying Li,Caixia Zhu,Yin Tong,Shujun Gao,Junwen Wang,Fang Wei,Qiliang Cai

DOI: https://doi.org/10.1158/1541-7786.27150983

2024-01-01

Abstract:Supplementary Table S1. Oligonucleotides.
Study on the effect of Shengmai Injection (生脉注射液) on the immune regulation of mice bearing hepatoma22 tumor

王鹏,陈震,黄雯霞,刘鲁明

DOI: https://doi.org/10.3969/j.issn.1001-859X.2005.06.001

2005-01-01

Abstract:Objective: To observe the effect of Shengmai Injection(SMI) on the immune regulation of mice bearing hepatoma_ 22 tumor. Methods: H_ 22 tumor bearing mice models were established and then divided randomly into five groups, including control group, adriamycin (ADM) group, SMI (high, medium and low dose)combined with ADM groups. There were 10 mice in each group. The five groups were injected introperitoneally with same amount of natural saline,ADM 2mg/kg and SMI(14ml/kg,7ml/kg and 3.5ml/kg)plus ADM 2mg/kg respectively, once a day for 14 days. After that, killed and observed the tumorweightinhibiting rates, T-cell subgroups and the level of IgA, IgG, IgM in the peripheral blood. Results: (1)The tumorweightinhibiting rates were higher in each SMI plus ADM group than that in the ADM group(P<0.05) ;(2)Compared with the control group, lower level of CD_3、CD_4、CD_4/CD_8 ratio and higher level of CD_8 were observed in the ADM group(P<0.05). But in the three SMI groups combined with ADM there showed higher level of CD_3、CD_4、CD_4/CD_8 ratio and lower level of CD_8 compared with control group,which showed significant difference(P<0.05).(3)Compared with the control group, The level of IgA、IgG and IgM were lower in ADM group.But in the three SMI plus ADM groups the level of IgA、IgG and IgM were higher (P<0.05). Conclusion: SMI can improve the immune function of tumor bearing mice and enhance the anti-tumor efficacy of chemotherapy.
Additional File 2 of Network Pharmacology -Based Study on the Mechanism of Traditional Chinese Medicine in the Treatment of Glioblastoma Multiforme

Chen Liang,Binbin Zhang,Ruichun Li,Shiwen Guo,Xiaoxuan Fan

DOI: https://doi.org/10.6084/m9.figshare.24209120

2023-01-01

Abstract:Additional file 2: Supplementary Table 2. Active ingredients and target genes of YQQYJDF.
Additional File 9 of Transcriptome-wide Analysis of RNA M6a Methylation Regulation of Muscle Development in Queshan Black Pigs

Yaqing Dou,Yilin Wei,Zhe Zhang,Feng Yang,Chenlei Li,Chenglei Song,Yingke Liu,Kunlong Qi,Xinjian Li,Xiuling Li,Ruimin Qiao,Kejun Wang,Xuelei Han

DOI: https://doi.org/10.6084/m9.figshare.22767543

2023-01-01

Abstract:Additional file 9: Table S9. All KEGG pathways for the DEGs.
Exploring the Mechanism of Shen Qi Gui Oral Liquid against Chemotherapy-Induced Myelosuppression in Cancer Patients Based on Network Pharmacology and Molecular Docking

Feng Wan,Qiao Zheng,Tiecheng Zhou,Hang Zhou,Fu Peng,Dejiao Yao,Cheng Peng

DOI: https://doi.org/10.2174/0113862073316774240708110250

2024-07-09

Combinatorial Chemistry & High Throughput Screening

Abstract:Background: Shen Qi Gui oral liquid (SQG) may be beneficial for chemotherapyinduced myelosuppression (CIM). However, the underlying mechanism of CIM treated with SQG is still lacking. Methods: A total of 27 blood samples from cancer patients were selected to perform RNA-seq to obtain the Differentially Expressed Genes (DEGs). Then, the active components and target genes of SQG were acquired. Next, the drug targets and DEGs were intersected to obtain the intersection genes, followed by functional enrichment analysis and construction of a drug-compoundgene- disease network. Subsequently, core genes were selected. Then, immune cell infiltration, molecular docking, pharmacokinetic and toxicity prediction, and RT-qPCR were performed. Results: A total of 1,341 DEGs, 51 active compounds, and 264 target genes were identified. Then, 30 intersection genes were acquired. Next, a drug-compound-gene-disease network was constructed, and 7 core genes were acquired. Immune infiltration analysis exhibited that only T follicular helper cells were significantly increased in the CIM group, which was significantly negatively correlated with MAPK1, MAPK14, MCL1, PTEN, and PTGS2. The luteolin, quercetin, and beta-sitosterol showed better affinity with core genes. Luteolin and quercetin, which satisfied Lipinski's rule of five, were likely absorbed by the gastrointestinal system. Toxicity predictions showed that neither luteolin nor quercetin exhibited carcinogenicity or hepatotoxicity. Conclusion: PTEN, PTGS2, CCL2, FOS, MCL1, MAPK1, and MAPK14 were identified as the core genes in CIM patients, which were involved in the MAPK and PI3K-Akt signaling pathways. Luteolin and quercetin may be the promising drugs against CIM.

pharmacology & pharmacy,biochemical research methods,chemistry, applied
Experimental Study on Anti-Tumor Efficacy of Shengmai Injection Combined with Oxaliplatin

WANG Peng,CHEN Zhen,HUANG Wen-xia,LIU Lu-ming

DOI: https://doi.org/10.3969/j.issn.1001-1528.2006.04.023

2006-01-01

Abstract:AIM: To observe the changes in tumor-weight-inhibiting rates,immunological function,liver and renal function and the blood cell in the peripheral blood after administration of Shengmai Injection combined with chemotherapeutic agent,Oxaliplatin. METHODS: Hepatoma 22 tumor bearing mice models were established and then divided randomly into five groups,including control group,Oxaliplatin group,Shengmai Injection(high,middle and low dose) combined with Oxaliplatin groups.Each group had 10 mice.The five groups were injected introperitoneally with same amount of 5% glucose injection,Oxaliplatin 6 mg/kg and Shengmai Injection(14 mL/kg,7 mL/kg and 3.5 mL/kg) plus Oxaliplatin 6 mg/kg respectively,once a day for 14 days. After that,mice in the five groups were all killed after being anesthetized and the tumor-weight-inhibiting rates and the index of immunological function,liver and renal function and the blood cell in the peripheral blood were observed. RESULTS: (1) The tumor-weight-inhibiting rates were higher in each Shengmai Injection plus Oxaliplatin group than that in the Oxaliplatin group (P0.05);(2)Compared with the control group,the level of CD3,CD4,CD4/CD8,IgG and IgM in Oxaliplatin group were lower(P0.05).But in the three Shengmai Injection groups combined with Oxaliplatin the level of CD3 CD4/CD8,IgG and IgM were higher than that in control group and Oxaliplatin group,which revealed significant difference(both P0.05).(3) The level of serum ALT was higher in Oxaliplatin group with lower WBC in the peripheral blood.But in the three Shengmai Injection plus Oxaliplatin groups the level of serum ALT were lower and WBC counts were higher than that in the Oxaliplatin group(P0.05). CONCLUSION:()The anti-tumor efficacy of Oxaliplatin can enhance when combined with Shengmai Injection,at the same time improve immune function and reduce side-effects.
Supplementary file from Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy

Xue-Bin Ran,Ling-Wen Ding,Qiao-Yang Sun,Henry Yang,Jonathan W. Said,Lao Zhentang,Vikas Madan,Pushkar Dakle,Jin-Fen Xiao,Xinyi Loh,Ying Li,Liang Xu,Xiao-Qiang Xiang,Ling-Zhi Wang,Boon Cher Goh,De-Chen Lin,Wee Joo Chng,Soo-Yong Tan,Sudhakar Jha,H. Phillip Koeffler

DOI: https://doi.org/10.1158/0008-5472.22432644.v1

2023-01-01

Abstract:<p>This file contains supplementary methods, Figs. S1 to S6 and Tables S1 to S5.</p>
[Effect of Shenqi Fuzheng Injection for Hemopoietic and Immune Function Reconstruction in Patients with Hematologic Malignancies Undergoing Chemotherapy].

Xiao-yu Zhu,Xiang-zhong Zhang,Xue-yun Zhong

2010-01-01

Abstract:OBJECTIVE To investigate the effect of Shenqi Fuzheng Injection (SFI) for hemopoietic and immune function reconstruction in patients with hematologic malignancies (HM) after chemotherapy. METHODS Eighty HM patients at remission inducing stage of initial treatment were randomly assigned to two groups, the treatment group treated with SFI (250 mL daily) plus chemotherapy and the control group only treated with chemotherapy for 14 days, with same supportive treatments administered to both. Levels of blood routine test, T lymphocyte subsets (CD3+, CD4+, CD4+ /CD8+) and B lymphocyte subsets CD3- CD19+ were determined before and after treatment, and the remission rate was assessed after treatment. RESULTS The remission rates in the two groups showed no significant difference [90% (36/40) vs 82.5% (33/40), P > 0.05] statistically. Levels of peripheral leucocyte count and hemoglobin as well as levels of CD3+, CD4+, CD4+ /CD8+; were significantly higher in the treatment group than in the control group (P < 0.05), but no significant difference was shown between groups in CD3- CD19+ level. CONCLUSION SFI can lighten the inhibition of chemotherapy on hemopoietic function of bone marrow, and promote its recovery, enhance the immune function, and improve the quality of life in patients with HM undergoing chemotherapy.

Additional File 9 of Carbohydrates and Ginsenosides in Shenmai Injection Jointly Improve Hematopoietic Function During Chemotherapy-Induced Myelosuppression in Mice

Additional File 5 of Carbohydrates and Ginsenosides in Shenmai Injection Jointly Improve Hematopoietic Function During Chemotherapy-Induced Myelosuppression in Mice

Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice

Shenfu Injection Protects Against Myelosuppression from Chemotherapy

Additional File 9 of CircCDKN2B-AS1 Interacts with IMP3 to Stabilize Hexokinase 2 Mrna and Facilitate Cervical Squamous Cell Carcinoma Aerobic Glycolysis Progression

Additional File 6 of Uric Acid Induced Hepatocytes Lipid Accumulation Through Regulation of Mir-149-5p/fgf21 Axis

[Antiangiogenesis of Ginsenoside Rg3 in Severe Combined Immunodeficient Mice with Human Ovarian Carcinoma].

Study on the Effect of Ginsenosides Rb on Blood of Tumor Mice

Echinacoside Improves Hematopoietic Function in 5-Fu-induced Myelosuppression Mice

Transcriptome Profiling Analysis Reveals the Potential Mechanisms of Three Bioactive Ingredients of Fufang E'jiao Jiang During Chemotherapy-Induced Myelosuppression in Mice

Study on Synergic Effect of Shengmai Injection and Adriamycin

Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice

Pharmacological and transcriptome profiling analyses of Fufang E'jiao Jiang during chemotherapy-induced myelosuppression in mice

Supplementary Table S1 from Lactate Induces Tumor Progression Via LAR Motif-Dependent Yin-Yang 1 Degradation

Study on the effect of Shengmai Injection (生脉注射液) on the immune regulation of mice bearing hepatoma22 tumor

Additional File 2 of Network Pharmacology -Based Study on the Mechanism of Traditional Chinese Medicine in the Treatment of Glioblastoma Multiforme

Additional File 9 of Transcriptome-wide Analysis of RNA M6a Methylation Regulation of Muscle Development in Queshan Black Pigs

Exploring the Mechanism of Shen Qi Gui Oral Liquid against Chemotherapy-Induced Myelosuppression in Cancer Patients Based on Network Pharmacology and Molecular Docking

Experimental Study on Anti-Tumor Efficacy of Shengmai Injection Combined with Oxaliplatin

Supplementary file from Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy

[Effect of Shenqi Fuzheng Injection for Hemopoietic and Immune Function Reconstruction in Patients with Hematologic Malignancies Undergoing Chemotherapy].